Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2008
06/17/2008CA2383114C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
06/17/2008CA2309202C Adenosine a1 receptor agonists
06/17/2008CA2302347C 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use for medicaments
06/17/2008CA2294457C Pharmaceutical composition for application to mucosa
06/17/2008CA2284732C Analogs of cocaine
06/17/2008CA2272291C Crf antagonistic quino- and quinazolines
06/17/2008CA2264118C Tetrahydroquinoline derivatives as eaa antagonists
06/17/2008CA2202487C Fused pyrrolocarbazoles
06/17/2008CA2188892C Use of an yttrium salt in a compound for the treatment of sensitive skin
06/17/2008CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii)
06/17/2008CA2163361C Therapeutic substituted guanidines
06/17/2008CA2146954C Breath activated nicotine inhalers
06/12/2008WO2008070780A1 Antagonist antibodies against ephb3
06/12/2008WO2008070661A1 Substituted pyrimidines as adenosine receptor antagonists
06/12/2008WO2008070583A2 Thrombopoietin mimetics
06/12/2008WO2008070529A2 A2a adenosine receptor antagonists
06/12/2008WO2008070305A2 1, 5-diphenyl-3-pyridinylamino-1, 5-dihydropyrrolidin-2-one as cbl' receptor modulator
06/12/2008WO2008070296A2 System and method for diagnosis and treatment of neuropsychiatric disorders
06/12/2008WO2008070284A2 Amyloid beta peptides and methods of uses thereof
06/12/2008WO2008070010A2 Hydroxylamine derivatives for the treatment of stroke
06/12/2008WO2008070000A2 Treatment of anxiety with eszopiclone
06/12/2008WO2008069997A1 Substituted diazepan compounds as orexin receptor antagonists
06/12/2008WO2008069726A1 Treatment of resistant schizophrenia and other cns disorders by the use of thioxanthenes
06/12/2008WO2008069691A1 Agent for preventing and treating a parkinson's disease
06/12/2008WO2008069688A2 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
06/12/2008WO2008069311A1 Tricyclic compound and medical use thereof
06/12/2008WO2008069242A1 Novel bicyclic heterocyclic compound
06/12/2008WO2008068424A2 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands
06/12/2008WO2008068277A1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
06/12/2008WO2008068265A1 Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases
06/12/2008WO2008068184A1 Indoles which act as via receptor antagonists
06/12/2008WO2008068171A1 Substituted pyrimidines and their use as jnk modulators
06/12/2008WO2008068157A1 2-aminoquinolines as 5-ht(5a) receptor antagonists
06/12/2008WO2008067863A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
06/12/2008WO2008067781A2 A method of purification of (s)-n-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride (duloxetine)
06/12/2008WO2008067752A1 A process for preparing optical pure milnacipran and its pharmaceutically accepted salts
06/12/2008WO2008067713A1 Compounds having substituted cyclopentane structure, their preparation methods and medical uses
06/12/2008WO2008067712A1 Compounds having substituted cyclopropane structure, preparation method and uses thereof
06/12/2008WO2008067711A1 Compounds having substituted 4-members ring structure and their medicine uses
06/12/2008WO2008067710A1 Substituted cyclohexane compounds, preparation methods and medicine uses thereof
06/12/2008WO2008067709A1 Substituted cyclobutane compounds, preparation methods and pharmaceutical uses thereof
06/12/2008WO2008067610A1 Method for reducing inflammatory responses and inflammation
06/12/2008WO2008048648A3 Cb1-modulating compounds and their use
06/12/2008WO2008046581A3 Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments
06/12/2008WO2008045391A3 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
06/12/2008WO2008037888A3 Tetracyclic compounds, process for the preparation thereof pharmaceutical compositions comprising the same and use thereof as dopaminergic receptor ligands
06/12/2008WO2008037416A3 Use of theogallin for the treatment of mental concentration disorders, depression and dementia
06/12/2008WO2007148208A3 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
06/12/2008WO2007143523A3 Fused, tricyclic sulfonamide inhibitors of gamma secretase
06/12/2008WO2007134868A3 3,5-dihydroxy-2,4-cyclohexadienones and their derivatives, dietary compositions and fortified food containing them and their uses
06/12/2008WO2007132292A3 Therapy for alzheimer's disease
06/12/2008WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases
06/12/2008WO2007098273A3 Novel crystalline forms of armodafinil and preparation thereof
06/12/2008WO2007089548A3 Compounds and methods for modulating protein trafficking
06/12/2008WO2007073194A3 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
06/12/2008WO2007005879A3 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
06/12/2008US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
06/12/2008US20080139808 Crystal forms of lamotrigine and processes for their preparations
06/12/2008US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
06/12/2008US20080139664 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
06/12/2008US20080139662 Such as 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
06/12/2008US20080139659 Reducing intracranial pressure with sulfonylurea receptor 1 antagonist
06/12/2008US20080139657 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)hydroxycitric acid, and related compositions thereof
06/12/2008US20080139655 Consistant activation of brain dopamine receptors over time; reduced side effects from prolonged therapy; oral Parkinson's disease dosage form
06/12/2008US20080139651 Compounds useful for treating neurological disorders
06/12/2008US20080139641 Local anesthetic free; dentistry; side effect reduction
06/12/2008US20080139636 Adamantane derivatives
06/12/2008US20080139635 Inflammation Therapy
06/12/2008US20080139633 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement
06/12/2008US20080139624 Pellets; sustained release
06/12/2008US20080139621 Thrombocytopenia; administering a thrombopoietin receptor agonist; 4-(2-hydroxyphenyl)piperidin-1-yl-acetic acid; 3-(2-hydroxyphenyl)cyclohexane-carboxylic acid; 3-(3'-{2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazino}-2'-hydroxy-phenyl)cyclohexane-1-carboxylic acid
06/12/2008US20080139619 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments
06/12/2008US20080139618 Indoles
06/12/2008US20080139617 Indoles
06/12/2008US20080139614 Treatment Of Stroke With Histamine H3 Inverse Agonists Or Histamine H3 Antagonists
06/12/2008US20080139610 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
06/12/2008US20080139600 e.g. N,N-dimethyl-1-{5-[(2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridin]-5'-yl]-2-thienyl}methenamine; anxiolytic agent, antidepressant, cognition activator; neurodegenerative disorders: Alzheimer's, Parkinson's, Huntington's diseases, Tourette's syndrome, schizophrenia
06/12/2008US20080139598 e.g. N-(3'-chloro-3-methylbiphenyl-4-yl)-1-(pyrimidin-2-yl)piperidin-4-amine; proline transporter inhibitor; cognition activator; Alzheimer's disease, Attention-Deficit/Hyperactivity Disorder, autism, Down syndrome, Fragile X syndrome, Huntington's disease, Parkinson's disease, schizophrenia, dementia
06/12/2008US20080139591 CGRP Antagonists
06/12/2008US20080139589 2-Methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone; sleep, psychological, nervous system, and attention deficit disorders; drug abuse, alcoholism; antidiabetic agents, cognition activators; Alzheimer's and Parkinson's disease; histamine H3 receptor antagonists
06/12/2008US20080139583 Phosphodiesterase 4 inhibitors
06/12/2008US20080139580 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
06/12/2008US20080139573 Administering thioxanthene derivative such as zuclopenthixol, zuclopenthioxol acetate or decanoate, thiotixene, chlorothixene or flupenthixol or salts thereof; depression or bipolar disorder condition resistant to antipsychotic drugs
06/12/2008US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome
06/12/2008US20080139564 Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators
06/12/2008US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors
06/12/2008US20080139556 1-(3-Trifluoromethyl-benzenesulfonyl)-piperidine-2-carboxylic acid [(S)-1-(4-dimethylamino-phenylcarbamoyl)-2-(4-methoxy-phenyl)-ethyl]-amide;FK-binding protein/immunophilins modulator; neurodegenerative diseases; Parkinson's disease, multiple sclerosis, Alzheimer's disease, stroke, spinal cord injury
06/12/2008US20080139555 1-[(4-{[4-(3-amino-6-methylphenyl)piperidyl]methyl}phenyl)sulfonyl]-4; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent
06/12/2008US20080139552 Indoles
06/12/2008US20080139550 e.g. {5-Chloro-2-[4-(2-oxo-2,3-dihydro-benzooxazol-7-yl)-piperidine-1-carbonyl]-1H-indol-7-yl}-acetonitrile; vasopressin receptors antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, obsessive compulsive disorder
06/12/2008US20080139549 Indoles
06/12/2008US20080139548 Indoles
06/12/2008US20080139546 e.g. 3-(3,4-dihydroquinolin-1(2H)-yl)-N-{[8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinolin-2-yl]methyl}propan-1-amine; modulators of serotonin 5-HT1A receptor activity and/or serotonin reuptake; antidepressant, anxiolytic agent, cognition activator; schizophrenia, sexual disorders
06/12/2008US20080139541 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-(4-chloro)carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis
06/12/2008US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
06/12/2008US20080139532 Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents)
06/12/2008US20080139529 Nervous system, neurodegenerative, psychiatric, sexual, attention deficit, and psychological disorders; cognition activators, antidepressants, anxiolytic agents; alcoholism, drug abuse, traumas, strokes, epilepsy, schizophrenia, autism, and/or Alzheimer's disease treatment
06/12/2008US20080139523 Oxime-containing macrocyclic acyl guanidines as beta-secretase inhibitors
06/12/2008US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents
06/12/2008US20080139517 Administering therapeutically effective amount of at least one agent capable of inhibiting a neuronal cell cycle progression for therapy of age associated memory impairment, mild cognitive impairment (MCI), Alzheimer's disease, alone or in combination with agent capable of reducing mitogenic stimulation
1 ... 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 ... 1833